motion requested additional information under two main headings 
(text of motion included in table folders) ; motion unanimously 
accepted by Subcommittee; agreement by Subcommittee to review any 
additional data submitted by September 15th. 
September 9, 1988; submission of additional data to Dr. 
McGarrity, RAC Chairman, by Drs. Anderson, Blaese, and Rosenberg 
(tab 1337, pp. 353-367) . 
September 20, 1988: mailing of additional data to members of 
Human Gene Therapy Subcommittee by ORDA. 
September 29, 1988; conference call by members of and 
consultants to Subcommittee; 10 of 14 Subcommittee members and 
three of four consultants to Subcommittee participated in call; 
an eleventh Subcommittee member had phoned in comments before 
conference call; Subcommittee also heard written comments on 
proposed amendment that had been submitted by Dr. Albert H. 
Owens, Jr., Director of the Oncology Center at Johns Hopkins 
University (letter in table folder); unanimous judgment reached 
by Subcommittee members and consultants participating in 
conference call (see minutes of conference call in table folder); 
several members of Subcommittee who are also RAC members agreed 
to draft summary of Subcommittee's judgment for presentation to 
RAC on October 3rd. 
LeRoy Walters 
October 3, 1988 
[224] 
Recombinant DNA Research, Volume 13 
